Hematopoietic Stem Cell Clinical Trials

93 recruitingLast updated: July 25, 2026

There are 93 actively recruiting hematopoietic stem cell clinical trials across 19 countries. Studies span Not Applicable, Phase 2, Phase 1, Phase 3, Early Phase 1, Phase 4. Top locations include Suzhou, Jiangsu, China, Boston, Massachusetts, United States, Bethesda, Maryland, United States. Updated daily from ClinicalTrials.gov.


Hematopoietic Stem Cell Trials at a Glance

93 actively recruiting trials for hematopoietic stem cell are listed on ClinicalTrialsFinder across 6 cities in 19 countries. The largest study group is Not Applicable with 24 trials, with the heaviest enrollment activity in Suzhou, Boston, and Bethesda. Lead sponsors running hematopoietic stem cell studies include The First Affiliated Hospital of Soochow University, National Cancer Institute (NCI), and Children's Hospital Medical Center, Cincinnati.

Browse hematopoietic stem cell trials by phase

Treatments under study

About Hematopoietic Stem Cell Clinical Trials

Looking for clinical trials for Hematopoietic Stem Cell? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Hematopoietic Stem Cell trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Hematopoietic Stem Cell clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 93 trials

Recruiting
Not Applicable

HematoCare: Feasibility of a Survivorship Care Plan for Hematologic Cancer Patients Undergoing HSCT

SurvivorshipHematopoietic Stem Cell TransplantationCancer Survivorship+1 more
Azienda USL Reggio Emilia - IRCCS40 enrolled1 locationNCT07579065
Recruiting
Phase 1Phase 2

Study to Evaluate the Safety and Effectiveness of Withaferin A as a Treatment to Prevent GvHD in Transplant Patients

Hematopoietic Stem Cell Transplant (HSCT)Hematological MalignancyGVHD - Graft-Versus-Host Disease
Tata Memorial Centre54 enrolled2 locationsNCT07724873
Recruiting
Phase 2

To Study Lower Dose of Cyclophosphamide After Stem Cell Transplant for Blood Cancers

Hematological MalignanciesHaploidentical Hematopoietic Stem Cell Transplant
Tata Memorial Centre20 enrolled2 locationsNCT07719946
Recruiting
Phase 2

Chlorophyllin for Reducing Oral Mucositis in Total Body Irradiation Prior to Transplant

Oral MucositisHematopoietic Stem Cell Transplantation (HSCT)Hematological Malignancies+1 more
Tata Memorial Centre17 enrolled1 locationNCT07709195
Recruiting

Long-Term Follow up of Patients Undergoing Hematopoietic Stem Cell Transplantation, Cellular Therapy, or Gene Therapy

Hematopoietic Stem Cell TransplantationTissue DonorsCellular Immunotherapy, Adoptive+1 more
National Cancer Institute (NCI)2,000 enrolled1 locationNCT03000244
Recruiting
Not Applicable

Longitudinal Early Advance Care Planning Discussions and Documentation (LEADD) Program: An Exploratory Study in Adolescents and Young Adults (AYAs) Receiving Hematopoietic Stem Cell Transplant

Hematopoietic Stem Cell Transplantation
National Cancer Institute (NCI)222 enrolled2 locationsNCT05605574
Recruiting
Not Applicable

Coping Skills Training for Symptom Management and Daily Steps (Step Up)

Hematopoietic Stem Cell TransplantCAR-T Cell Therapy
Duke University177 enrolled1 locationNCT06575712
Recruiting
Phase 3

Single-Dose vs. Divided-Dose G-CSF for Stem Cell Mobilization in Healthy Allogeneic Donors

Healthy Hematopoietic Stem Cell DonorHealthy Allogeneic Hematopoietic Stem Cell Donor
First Affiliated Hospital of Zhejiang University560 enrolled8 locationsNCT07692841
Recruiting

Early Detection of Infectious and Noninfectious Lung Diseases Following Allogeneic Hematopoietic Stem Cell Transplantation

Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
National Heart, Lung, and Blood Institute (NHLBI)40 enrolled1 locationNCT06093867
Recruiting
Phase 2

A Phase II Study of Allogeneic Hematopoietic Stem Cell Transplant for Subjects With VEXAS (Vacuoles, E1 Enzyme, X-linked, Autoinflammatory, Somatic) Syndrome

Hematopoietic Stem Cell TransplantationImmunodeficiency
National Cancer Institute (NCI)54 enrolled1 locationNCT05027945
Recruiting

CMV-CMI in csCMVi After HSCT

Hematopoietic Stem Cell Transplantation (HSCT)Immune ReconstitutionCytomegalovirus Infections
The First Affiliated Hospital of Soochow University40 enrolled1 locationNCT07688759
Recruiting
Phase 2

Venetoclax Combined With Azacitidine for Consolidation Therapy in AML

Acute Myeloid LeukemiaConsolidation TherapyHigh-Risk+2 more
The First Affiliated Hospital of Soochow University216 enrolled1 locationNCT07425782
Recruiting
Phase 2

Ivosidenib as Post-HSCT Maintenance for AML

Acute Myeloid Leukemia (AML)IDH1 MutationHematopoietic Stem Cell Transplant (HSCT)
Massachusetts General Hospital75 enrolled6 locationsNCT06707493
Recruiting

TRANSPIRE: Lung Injury in a Longitudinal Cohort of Pediatric HSCT Patients

Hematopoietic Stem Cell Transplant (HSCT)Thrombotic MicroangiopathiesDiffuse Alveolar Hemorrhage+2 more
Children's Hospital Medical Center, Cincinnati2,000 enrolled9 locationsNCT04098445
Recruiting
Phase 4

Individualized Application of Anti-Thymocyte Globulin(ATG)in Unrelated Donor Hematopoietic Stem Cell Transplantation

Hematopoietic Stem Cell Transplantation
Daihong Liu324 enrolled1 locationNCT07648992
Recruiting
Phase 1Phase 2

The Lowest Effective Dose of Post-Transplantation Cyclophosphamide in Combination With Sirolimus and Mycophenolate Mofetil as Graft-Versus-Host Disease Prophylaxis After Reduced Intensity Conditioning and Peripheral Blood Stem Cell Transplantation

Hematopoietic Stem Cell TransplantationPeripheral Blood Stem Cell Transplantation
National Cancer Institute (NCI)260 enrolled2 locationsNCT05436418
Recruiting

ATLG Levels in Autologous HSCT for Multiple Sclerosis

Multiple SclerosisAutologous Hematopoietic Stem Cell TransplantATLG
Ciceri Fabio20 enrolled1 locationNCT07635693
Recruiting
Early Phase 1

Antigen Specific Adoptive T Cell Therapy for Adenovirus Infection After Hematopoietic Stem Cell Transplantation

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION
Mari Dallas20 enrolled1 locationNCT03378102
Recruiting
Phase 1Phase 2

Ruxolitinib-Enhanced Haplo HCT for Children and Young Adults With Sickle Cell Disease

Sickle Cell DiseaseGraft FailureHematopoetic Stem Cell Transplant+2 more
Arkansas Children's Hospital Research Institute24 enrolled4 locationsNCT07252050
Recruiting
Phase 4

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationCytomegalovirus Infections+1 more
WeiShi120 enrolled12 locationsNCT07569653